- Characterization of RhoA-mediated Chemoresistance in Gastric Cancer Cells
-
Kang WK, Lee I, Park C
- KMID: 1804580
- Cancer Res Treat.
- 2005 Aug;37(4):251-256.
PURPOSE: RhoA is a critical transducer of extracellular signals, which leads to organization of actin cytoskeleton, motility, adhesion and gene regulation. The present study aimed to explore whether RhoA influences... -
- CITED
-
- Close
- SHARE
-
- Close
- The Relationship between Expression of the Sodium/iodide Symporter Gene and the Status of Hormonal Receptors in Human Breast Cancer Tissue
-
Oh HJ, Chung JK, Kang JH, Kang WJ, Noh DY, Park IA, Jeong JM, Lee DS, Lee MC
- KMID: 1804579
- Cancer Res Treat.
- 2005 Aug;37(4):247-250.
PURPOSE: It has been reported that the sodium/iodide symporter (NIS) gene is expressed in several breast cancer tissues, suggesting the possibility of radionuclide imaging and therapy. However, the regulatory mechanism... -
- CITED
-
- Close
- SHARE
-
- Close
- The Immunoexpressions and Prognostic Significance of Inhibin Alpha and Beta Human Chorionic Gonadotrophins (hCG) in Breast Carcinomas
-
Chang E, Lee E, Oh SJ, Kim JS, Kang C
- KMID: 1804578
- Cancer Res Treat.
- 2005 Aug;37(4):241-246.
PURPOSE: Pregnancy and hCG treatments are considered essential for inhibiting breast cancer. The effect of hCG is accompanied by the synthesis of inhibin, a transforming growth factor involved in cell... -
- CITED
-
- Close
- SHARE
-
- Close
- Expression of Maspin is associated with the Intestinal Type of Gastric Adenocarcinoma
-
Kim SM, Cho SJ, Jang WY, Kim DH, Shin HS, Jang MK, Kim HY, Nam ES
- KMID: 1804576
- Cancer Res Treat.
- 2005 Aug;37(4):228-232.
PURPOSE: Maspin is known as a tumor suppressor gene, but its significance has been questioned in various human cancers. The aim of this study was to investigate the expression pattern... -
- CITED
-
- Close
- SHARE
-
- Close
- A Feasibility Study of Adenosine Triphosphate-based Chemotherapy Response Assay (ATP-CRA) as a Chemosensitivity Test for Lung Cancer
-
Kang SM, Park MS, Chang J, Kim SK, Kim H, Shin DH, Chung KY, Kim DJ, Sohn JH, Choi SH, Kim J, Yoon EJ, Kim JH
- KMID: 1804575
- Cancer Res Treat.
- 2005 Aug;37(4):223-227.
PURPOSE: A chemosensitivity test can reflect the differences in responses of individual cancer patients to chemotherapeutic agents. The adenosine triphosphate-based chemotherapy response assay (ATP-CRA)is an accurate method, which does not... -
- CITED
-
- Close
- SHARE
-
- Close
- Gene Promoter Hypermethylation in Tumors and Plasma of Breast Cancer Patients
-
Bae YK, Shim YR, Choi JH, Kim MJ, Gabrielson E, Lee SJ, Hwang TY, Shin SO
- KMID: 1804577
- Cancer Res Treat.
- 2005 Aug;37(4):233-240.
PURPOSE: To measure the hypermethylation of four genes in primary tumors and paired plasma samples to determine the feasibility of gene promoter hypermethylation markers for detecting breast cancer in the... -
- CITED
-
- Close
- SHARE
-
- Close
- Thymidylate Synthase, Thymidine Phosphorylase, VEGF and p53 Protein Expression in Primary Colorectal Cancer for Predicting Response to 5-fluorouracil-based Chemotherapy
-
Ahn MJ, Choi JH, Oh HS, Lee YY, Kim IS, Choi IY, Lee KH, Song KW, Park CK
- KMID: 1804574
- Cancer Res Treat.
- 2005 Aug;37(4):216-222.
PURPOSE: In the treatment of advanced metastatic colorectal cancer, several new agents, such as irinotecan and oxaliplatin, have been developed, which have improved both disease free and overall survivals. Among... -
- CITED
-
- Close
- SHARE
-
- Close
- Oxaliplatin/5-FU without Leucovorin Chemotherapy in Metastatic Colorectal Cancer
-
Shim BY, Lee KM, Cho HM, Kim HJ, Cho HJ, Yang J, Kim JG, Kim HK
- KMID: 1804573
- Cancer Res Treat.
- 2005 Aug;37(4):212-215.
PURPOSE: Fluorouracil (5-FU) and leucovorin combination therapy have shown synergistic or additive effect against advanced colorectal cancer, but the frequency of mucositis and diarrhea is increased. Most previous studies have... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy and Safety Study of Docetaxel as Salvage Chemotherapy in Metastatic Gastric Cancer Failing Fluoropyrimidine and Platinum Combination Chemotherapy
-
Lee JL, Ryu MH, Chang HM, Kim TW, Yook JH, Oh ST, Kim BS, Lee JS, Kang YK
- KMID: 1804571
- Cancer Res Treat.
- 2005 Aug;37(4):201-207.
PURPOSE: Fluoropyrimidine (F) and platinum (P) combination chemotherapy has been widely used for the first line treatment of advanced gastric cancer (AGC). Docetaxel (D) has shown promising activity in this... -
- CITED
-
- Close
- SHARE
-
- Close
- A Phase II Trial of Haptaplatin/5-FU and Leucovorin for Advanced Stomach Cancer
-
Lee WS, Lee GW, Kim HW, Lee OJ, Lee YJ, Ko GH, Lee JS, Jang JS, Ha WS
- KMID: 1804572
- Cancer Res Treat.
- 2005 Aug;37(4):208-211.
PURPOSE: Heptaplatin (SKI-2053 R) is a new platinum analogue, with a better toxicity profile than cisplatin, and has antitumor activity even in cisplatin resistant cell lines. 5-fluoruracil (5-FU) has shown... -
- CITED
-
- Close
- SHARE
-
- Close
